GRANTS

68 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Novel Genomic Technology Development (R01)

Sponsor: National Human Genome Research Institute

Award: An applicant may request direct costs of up to $700,000 per year.

Due Date: October 31, 2016; October 31, 2017, by 5 p.m. local time of applicant organization.

Novel Genomic Technology Development (R21)

Sponsor: National Human Genome Research Institute

Award: An applicant may request direct costs of up to $200,000 per year and no more than $400,000 for the entire budget period.

Due Date: October 31, 2016; October 31, 2017, by 5 p.m. local time of applicant organization.

Novel Genomic Technology Development (R43/R44)

Sponsor: National Human Genome Research Institute

Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1 million for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1.5 million for Phase II). NIH has received a waiver from SBA, as authorized by the statute, to exceed the hard cap for specific topics.

Due Date: October 31, 2016; October 31, 2017, by 5 p.m. local time of applicant organization.

Novel Genomic Technology Development Direct to Phase II SBIR (R44)

Sponsor: National Human Genome Research Institute

Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $1 million for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($1.5 million for Phase II). NIH has received a waiver from SBA, as authorized by the statute, to exceed the hard cap for specific topics.

Due Date: October 31, 2016, by 5 p.m. local time of applicant organization.

SBIR Technology Transfer (R43/R44)

Sponsor: National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences, National Cancer Institute, National Eye Institute, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Institute of Dental and Craniofacial Research, National Institute of Nursing Research

Award: Total funding support normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II). NIH can apply for a waiver from SBA to issue an award exceeding $225,000 for Phase I or $1,500,000 for Phase II, if this cap will interfere with NIH‘s ability to meet its mission.

Due Date: Multiple dates, see announcement.

Current Filters

No filters selected

Filter By